BSBR Santander BR reports sharp Q1 2023 EPS miss edges modestly higher as investors look past nearterm weakness Gladstone LAND Stock Strategic Buy or Not Q4 2025 Earnings Underperform ATHE Alterity publishes latest quarterly earnings report outlining new advancement plans for its lead neurological drug candidate